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Diversity-generating retroelements (DGRs) recognize novel ligands through massive protein sequence variation, a
property shared uniquely with the adaptive immune response. Little is known about how recognition is achieved by
DGR variable proteins. Here, we present the structure of the Bordetella bacteriophage DGR variable protein major
tropism determinant (Mtd) bound to the receptor pertactin, revealing remarkable adaptability in the static binding
sites of Mtd. Despite large dissimilarities in ligand binding mode, principles underlying selective recognition were
strikingly conserved between Mtd and immunoreceptors. Central to this was the differential amplification of binding
strengths by avidity (i.e., multivalency), which not only relaxed the demand for optimal complementarity between Mtd
and pertactin but also enhanced distinctions among binding events to provide selectivity. A quantitatively similar
balance between complementarity and avidity was observed for Bordetella bacteriophage DGR as occurs in the
immune system, suggesting that variable repertoires operate under a narrow set of conditions to recognize novel
ligands.
Citation: Miller JL, Le Coq J, Hodes A, Barbalat R, Miller JF, et al. (2008) Selective ligand recognition by a diversity-generating retroelement variable protein. PLoS Biol 6(6):
e131. doi:10.1371/journal.pbio.0060131
Introduction
The vertebrate adaptive immune response long has been
considered unique among biological systems in having the
capacity to recognize novel ligands in an anticipatory fashion
[1]. Such anticipatory recognition depends on antigen
receptors that accommodate massive sequence variation in
their ligand binding sites, which enables these receptors to
have vastly diverse binding specificities. In the immune
system of jawed vertebrates, antibodies and T cell receptors
(TCRs) have ligand binding sites that are estimated to
accommodate ;1014–16 potential amino acid sequences [2].
Likewise, in the immune system of jawless vertebrates,
lymphocyte receptors have binding sites that are estimated
to accommodate ;1014 potential sequences [3]. Recently, the
first instance outside the immune system of massive sequence
variability directed towards anticipatory recognition of novel
ligands was discovered in diversity-generating retroelements
(DGRs) [4].
DGRs have been identified in the genomes of 21 prokary-
otic organisms and bacteriophages to date [5] (M. Gingery
and J.F.M., unpublished data). The most extensively charac-
terized DGR is encoded by Bordetella bacteriophage, which is
capable of producing ;1013 potential sequences in the
variable protein major tropism determinant (Mtd) [4–7].
Mtd is a pyramid-shaped trimeric protein [7] that localizes to
the ends of phage tail fibers and functions as the phage’s
receptor-binding protein [4,6]. DGR-programmed variation
of Mtd enables the phage to use alternative Bordetella
receptors for infection [4]. This is essential to the phage
because the expression pattern of Bordetella surface molecules
(i.e., potential phage receptors) changes according to the
environmental status of the bacterium [4,8,9].
Environmentally influenced gene expression patterns in
Bordetella are regulated by the BvgAS two-component system,
with virulence factors being expressed exclusively in the in
vivo pathogenic or Bvgþ phase and genes required for
motility being expressed exclusively in the ex vivo or Bvg–
phase (Figure 1) [8–10]. Other genes are expressed preferen-
tially at intermediate levels of Bvg activation [11]. The Bvgþ-
specific adhesin pertactin [12,13] is the only Mtd receptor
whose identity is currently known [4,7] (Figure 1A), but the
existence of Bvg–-specific and other receptors has been
demonstrated genetically [4].
Variation in Mtd is focused on 12 adenine-encoded amino
acids that are fixed in position and scattered across its C-
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terminal region (Figure 1B). This pattern of variation is
governed by the template-based and adenine-specific mech-
anism of DGR mutagenesis [4]. The 12 variable residues are
organized into receptor-binding sites by the C-type lectin
fold of Mtd. There are three such independent receptor-
binding sites in trimeric Mtd, and these sites are located at
the bottom of the pyramid-shaped trimer (Figure 2 and
Figure S1) [7]. The backbone conformations of the receptor-
binding sites in Mtd are notably static to sequence variation.
Two factors appear to contribute to maintaining the static
nature of these sites. The first is trimeric assembly of the b2b3
loop of the C-type lectin fold, which braces the binding site of
a neighboring protomer (Figure S1). The second is the
presence of two insert regions, which surround and also brace
the binding site [7]. Sequence and structural evidence
indicates that other DGRs are likely to accommodate massive
sequence variation using the C-type lectin fold as well [5,7].
While the mode of antigen recognition by antibodies and
TCRs is well studied, no knowledge of how a DGR variable
protein recognizes its ligands is available. To address this, we
determined the structure of the Mtd-P1 variant [7] bound to
the Bvgþ-specific receptor pertactin. Mtd-P1 is expressed by
BPP-1 phage (Figure 1), and interaction between Mtd-P1 and
pertactin is required for infection by this phage [4]. This
interaction is sufficient for infection, as Bvg– Bordetella is
rendered permissive to BPP-1 infection through ectopic
expression of pertactin [4].
With structural knowledge in hand, we pursued the
question of why the relatively weak interaction (3 lM
dissociation constant, Kd) between Mtd-P1 and pertactin
supports infection [7], whereas a slightly weaker interaction
between Mtd-M1 and pertactin does not (Figure 1). Mtd-M1 is
a direct descendant of Mtd-P1 that binds pertactin [7] but is
incapable of using pertactin productively as a receptor for
infection; it instead uses an unidentified receptor expressed
by Bvg– Bordetella [4]. By comparing properties of these two
Mtd variants as well as of Mtd-P6, a pertactin-dependent
revertant of Mtd-M1 that closely resembles Mtd-M1 in
sequence (Figure 1), we identified avidity (i.e., multivalency)
as an essential determinant of selective infection. We found
that avidity not only served to expand the number of
productive interactions but also enhanced discrimination
among interactions. We suggest that these same principles
contribute to the robust and selective response of sequence
variable repertoires in the vertebrate adaptive immune
system.
Results
Recognition of Pertactin by Mtd-P1
We isolated, crystallized, and determined the structure of
Mtd-P1 (120 kDa per trimer) [7] bound to the 60 kDa
ectodomain of B. bronchiseptica pertactin (Prn-E; residues 38–
640). Pertactin is a b-helix protein that localizes to the
Bordetella outer membrane and belongs to the autotransport-
er family [12,13]. The 60 kDa ectodomain of pertactin is
proteolytically processed from a 93 kDa precursor and
remains tightly but noncovalently associated with the
bacterial cell surface [14,15]. Structure determination to
Figure 1. Tropism and Receptor Specificities of Bordetella Bacterioph-
ages
(A) The Mtd-P1 variant is expressed by BPP-1 phage and sets the tropism
of the phage to Bvgþ Bordetella due to recognition of the Bvgþ-specific
receptor pertactin. The Mtd-M1 variant is a direct descendant of Mtd-P1
and is expressed by BMP-1 phage. It sets tropism to Bvg– Bordetella
through recognition of an unidentified receptor. Mtd-M1 also binds
pertactin, albeit nonproductively. The Mtd-P6 variant is a direct
descendant of Mtd-M1 and is expressed by BPP-6 phage. It sets the
tropism of BPP-6 to Bvgþ Bordetella due to recognition of pertactin.
(B) Variable region sequences of Mtd-P1, Mtd-M1, and Mtd-P6. Variable
residues are in color, and invariant residues in black. For Mtd-P1, variable
residues are in blue. For Mtd-M1, variable residues in common with Mtd-
P1 are in blue, and those unique to Mtd-M1 are in green. For Mtd-P6,
residues in common with Mtd-M1 or Mtd-P1 are in green or blue,
respectively, and those unique to Mtd-P6 are in red. Mtd has 381
residues in total.
doi:10.1371/journal.pbio.0060131.g001
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Author Summary
The immune system long has been considered unique in its capacity
to recognize alien molecules. This anticipatory recognition depends
on a repertoire of receptors—antibodies and T cell receptors—with
binding sites capable of accommodating trillions of different amino
acid sequence combinations. A similar capacity was discovered
recently in diversity-generating retroelements (DGRs), which are
encoded by prokaryotes and the bacteriophages that infect them.
The receptor-binding protein Mtd of Bordetella bacteriophage is
encoded by a DGR and accommodates trillions of sequences in its
binding site. DGR-programmed variation of Mtd allows the phage to
use alternative host receptors—an ability that is crucial for phage
infection because the expression pattern of these host receptors
changes according to the environmental status of the bacterium.
We sought to understand how Mtd recognizes receptors by
determining the structure of an Mtd variant bound to the host
receptor pertactin. With this structural knowledge, we then
compared the binding properties of different variants and their
ability to support phage infection. Despite large differences in
physical details between Mtd and immunoreceptors, general
principles emerged through which variable repertoires achieve
selective molecule recognition, providing a view of how the Mtd
family can rapidly evolve novel specificities.
3.16 A˚ resolution revealed that a single Mtd-P1 trimer,
although possessing three independent receptor-binding
sites, associated with just one Prn-E molecule (Figure 2).
The 3:1 Mtd-P1/Prn-E stoichiometry is consistent with
measurements made in solution [7]. Two independent copies
of the ;180 kDa Mtd-P1Prn-E complex occupied the
asymmetric unit of the crystal (Table S1). Except for certain
unbound loops of pertactin, molecular details were unam-
biguous and nearly identical in the two Mtd-P1Prn-E
complexes. No large conformational changes occurred in
Mtd-P1 upon binding [7], and while the structure of free B.
bronchiseptica Prn-E is not known, comparison to the structure
of the closely related free B. pertussis Prn-E [12] suggested no
large conformational changes occurred in pertactin upon
binding.
A total of ;2300 A˚2 was buried at the Mtd-P1Prn-E
interface. This large figure compares favorably with the 1680
A˚2 of an average antibody–antigen interface [16]. The
majority of the Mtd-P1Prn-E surface (66%) was composed
of hydrophobic residues, which is consistent with prior
characterization of this association as being entropically
driven [7]. About three-fourths of the buried surface area
came from residues that were in atomic contact (4 A˚), and
the remaining from residues that were not in contact but
Figure 2. Structure of Mtd-P1 Bound to Prn-E.
(A) (Top left) The Mtd-P1Prn-E complex is depicted in molecular surface representation, with each protomer in the Mtd-P1 trimer colored a different
shade of gray and Prn-E colored blue. The trimer axis of Mtd is depicted by a gray triangle at the top. One site of trimeric Mtd binds the major pertactin
loop (399–407); a second site binds the minor pertactin loop (residues 190–199); the third site is empty. (Bottom left) Arrow designates a 908 rotation,
which exposes the empty site to view. (Top right) Arrows designate 908 rotations (Mtd rotated back toward page, Prn-E forward toward viewer) that
expose the interacting surfaces to view (green, hydrophobic contacts; red, hydrophilic contacts; yellow, hydrophobic buried; purple, hydrophilic buried).
Contact residues are those having an interatomic distance between Mtd-P1 and Prn-E of 4 A˚, and buried residues are those having an interatomic
distance of .4 A˚ and excluding water due to association.
(B) The Mtd-P1Prn-E complex is depicted in ribbon representation (Mtd protomers in red, pink, and purple and Prn-E in blue). Prn-E loops that contact
Mtd-P1 are green and labeled. The trimer axis of Mtd is depicted by a gray triangle at the top. For reference, the RGD loop of pertactin is shown in light
gray in the conformation observed for B. pertussis pertactin [12] but was not modeled in the structure of the Mtd-P1Prn-E complex.
doi:10.1371/journal.pbio.0060131.g002
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close enough to have excluded water (Figure 2 and Tables S2
and S3).
Two loops of pertactin emanating from its b-helix scaffold
contacted Mtd. These loops nestled separately into two of the
three receptor-binding sites of Mtd (Figures 2 and 3). The
third receptor-binding site of Mtd was unoccupied and
sterically occluded from binding another Prn-E molecule.
One of the contacting pertactin loops, composed of residues
399–407, formed the majority of the interactions with a total
of ;870 A˚2 being buried at this interface and was called the
‘‘major loop’’. The other loop, composed of residues 190–199,
made less extensive but nevertheless essential interactions
(see below), with a total of ;585 A˚2 being buried at this
interface, and was called the ‘‘minor loop’’.
The receptor-binding sites in Mtd-P1 consisted of shallow
pockets that contained a central cluster of aromatic residues
Figure 3. Mtd-P1 Receptor-Binding Sites
(A) The Mtd-P1Prn-E complex is depicted with Mtd-P1 in molecular surface representation and Prn-E in yellow stick representation. The view is looking
at the base of the pyramid-shaped Mtd trimer. The surfaces of the Mtd sites that bind the major and minor pertactin loops are colored (green,
hydrophobic residues; red, hydrophilic residues).
(B) Contacts between Mtd-P1 and the major pertactin loop. Mtd-P1 is depicted in molecular surface representation, as in (A). Backbone atoms of the
Mtd-P1 variable region are depicted in gray curvilinear representation, and side chain carbons, oxygens, and nitrogens in gray, red, and blue,
respectively. Mtd-P1 residues are labeled in blue. The major loop of Prn-E (residues 399–407, sequence below panel) is depicted in stick representation
(backbone in yellow and side chain carbons, oxygens, and nitrogens in yellow, red, and blue, respectively). Prn-E residues are labeled in black. The
backbone carbonyls of Prn-E Pro403 and Pro405 are also depicted.
(C) Contacts between Mtd-P1 and the minor pertactin loop, depicted as in (B).
(D and E). Hydrogen bonds to (D) major and (E) minor pertactin loops are shown as cyan dashed lines. Atom coloring is as in panels (B) and (C).
doi:10.1371/journal.pbio.0060131.g003
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and a stripe of polar residues along one edge (Figure 3B and
3C). Relatively planar interfaces also occur in antibody–
protein complexes [17]. Aromatic residues of Mtd dominated
the interactions with both the major and the minor loops of
pertactin. The variable Mtd residues Tyr359, Phe366, and
Phe368 and the invariant Mtd residues Tyr322 and Tyr333
were particularly significant in terms of buried surface area
(Table S2). Tyrosines are also dominant at antibody–antigen
interfaces, forming ;25% of these contacts [18]. The
invariant Mtd residues Tyr322 and Tyr333 are located on
the b2b3 loop, which infiltrates into the binding site from a
neighboring protomer (Figure S1) [7]. The involvement of
these b2b3 loop tyrosines in binding reinforced the notion
that the trimeric nature of Mtd was essential for function [7].
Although the three separate and independent binding sites of
Mtd-P1 interacted with different chemical environments,
they were strikingly indistinguishable in conformation from
one another and from unbound Mtd-P1 (Figure 4).
Pertactin buried mostly hydrophobic residues (Leu401,
Pro403, Ile404, and Pro405) from the major loop 399–407
within the Mtd aromatic cluster in one binding site and
Leu191, Gln192, and Leu194 from the minor loop 190–199 in
a second binding site (Figure 3B and 3C and Table S3). The
hydrogen bonding capacity of pertactin Gln192 in the minor
loop appeared to be satisfied by the invariant Mtd residues
Tyr322 and Tyr333 (Figure 3E). In addition, it appeared that
two hydrogen bonds were formed to the main chain carbonyl
atoms of the major loop (Figure 3D).
The major and minor pertactin loops have no obvious
sequence relationship to each other, and unlike other regions
of pertactin, neither loop is antigenically variant [19]. The
conformations of the major and minor loops in their free state
are not known, but these and other pertactin loops are likely to
be highly flexible, as deduced from the structure of free B.
pertussis pertactin [12]. On the basis of this evidence, we suspect
that the major and minor loops of B. bronchiseptica pertactin
probably differ in conformation between bound and free states
(Figure S2). Residues interacting with Mtd-P1 are conserved
between B. bronchiseptica and B. pertussis, except for Pro403,
which is substituted by Ser. The substitution was tolerated, as
Mtd-P1 bound B. pertussis Prn-E (unpublished data).
Most notably, the shape fit between Mtd and pertactin
resembled an antibody–antigen complex as quantified by
surface complementarity (SC) [20]. Complexes that have
undergone evolutionary fine-tuning have high SC values of
0.70–0.74 (e.g., 0.77 for the interprotomer interfaces of Mtd,
where 1.0 is perfect complementarity), whereas antibody–
antigen interfaces have lower SC values of 0.64–0.68,
reflecting their anticipatory and non-coevolved fit. Mtd-P1
bound the major and minor loops with SC values of 0.67 and
0.62, respectively, which distinguished these interactions as
antibody-like. The small adjustments seen in side chain
positions of Mtd-P1 upon binding were important for
achieving this shape fit (Figure 4B), as documented by the
lower SC values of 0.55 and 0.56 for free Mtd-P1 modeled in
complex with the major and minor loops, respectively.
Differences between Productive and Nonproductive
Interactions with Pertactin
We next pursued the question of why interaction between
Mtd-P1 and pertactin leads to infection but interaction
between Mtd-M1 and pertactin does not (Figure 1). Mtd-M1 is
a direct descendant of Mtd-P1 known to bind pertactin, but
unlike Mtd-P1, this interaction is nonproductive and does not
lead to infection [4,7]. Exactly 9 of 12 variable residues differ
between Mtd-P1 and Mtd-M1, with most of the aromatic
cluster in Mtd-P1 substituted by polar residues, as shown by
direct structural comparison [7] (Figure 1B and Figure S3).
These nine changes are sufficient to switch specificity from
pertactin to an unknown receptor expressed exclusively by
Bvg– Bordetella [4], possibly glycans of the O-antigen as
implicated by genetic evidence (unpublished data).
Figure 4. Superposition of Mtd-P1 Variable Regions
(A) Mtd-P1 sites from the Mtd-P1Prn-E complex that bind the major (orange) or minor (green) pertactin loops or no pertactin loop (cyan) are
superposed (average root-mean-square deviation 0.303 A˚ for 376 Ca atoms). The backbone is shown in curvilinear representation, and side chains of
variable residues, along with the invariant residues Tyr322 and Tyr333, are shown in stick representation. Variable residues are labeled in blue, and
invariant ones in black.
(B) The Mtd-P1 site from the Mtd-P1Prn-E complex that binds the major pertactin loop (gray) is superimposed with a site from unbound Mtd-P1 (blue)
(root-mean-square deviation 0.450 A˚ for 376 Ca atoms).
doi:10.1371/journal.pbio.0060131.g004
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With structural evidence having identified the 190–199 and
399–407 loops as the pertactin epitope for Mtd-P1, we asked
whether Mtd-M1 shares this epitope. Major and minor
pertactin loop deletion mutants were constructed, and
purified His-tagged Prn-E mutants were assayed for associa-
tion with Mtd-P1 in an in vitro coprecipitation assay. We
found that loss of either the major (Prn-E D399–407) or
minor (Prn-E D190–199) pertactin loop severely attenuated
association with Mtd-P1 as compared to that of wild-type
Prn-E (Figure 5A and 5B). This indicated that both major and
minor loops were necessary for association with Mtd-P1 and,
conversely, that each of the Mtd sites contacting pertactin
conferred a portion of the affinity. In contrast, Mtd-M1
bound Prn-E D399–407 equally well as wild-type Prn-E
(Figure 5A and 5B), which indicated that the major loop
was not required for association with Mtd-M1. The minor
loop 190–199 appeared to form at least part of the epitope
for Mtd-M1, as deletion of this loop reduced binding
substantially (Figure 5A and 5B). However, we note that
interaction between Mtd-M1 and pertactin was weak and that
partial loss of binding would thus be difficult to differentiate
from complete loss in this assay. These results indicated that
Mtd-M1 did not retain the same pertactin epitope as Mtd-P1
but fortuitously bound a separate epitope that contained, at
least in part, loop 190–199.
Evolution of Productive Interactions
To gain further insight into the selectivity of infection, we
isolated pertactin-dependent revertants of Mtd-M1. The most
informative revertant was Mtd-P6, which was expressed by
BPP-6 phage and differed at only 5 of 12 variable residues
from Mtd-M1 (Figure 1). These five changes were modeled
with high confidence due to the static nature of Mtd and
predicted to enlarge the hydrophobic portion of the binding
site and segregate hydrophobic from polar areas (Figure S3).
As with Mtd-M1, deletion of major loop 399–407 in Prn-E
did not abrogate association with Mtd-P6 (Figure 5A and 5B).
Deletion of the minor loop 190–199 reduced association but
not fully, which indicated that the pertactin epitope for Mtd-
P6 involved loop 190–199, at least in part. This pattern closely
resembled that of Mtd-M1, and due to the close sequence
similarity between Mtd-M1 and Mtd-P6, it strongly suggested
that these two Mtd variants had a shared pertactin epitope.
To quantify the affinity of Mtd-P6 for pertactin, we turned
to surface plasmon resonance (SPR) with biotinylated Prn-E
immobilized on the surface of a streptavidin chip (Figure 6
and Figure S4). First, we validated the SPR experiment by
examining association of Mtd-P1 with surface-immobilized
pertactin. The Kd determined by SPR for Mtd-P1Prn-E was
3.47 6 0.13 lM (Table 1), agreeing almost exactly with the
prior isothermal titration calorimetry measurement of 3.04
6 0.48 lM [7]. The affinity of Mtd-M1 for pertactin was too
low to be detected by SPR, as had also been the case for
isothermal titration calorimetry, but a coprecipitation assay
provided an estimate of ;0.5 mM for its apparent Kd (Figure
S5 and Materials and Methods section). A similar value was
obtained by considering limits of detection in the SPR
experiment (Materials and Methods section). By comparison,
the Kd of Mtd-P6 for pertactin was 5.19 6 3.07 lM by SPR,
which demonstrated that some or all of the five differences
between Mtd-M1 and Mtd-P6 resulted in a;100-fold increase
in affinity for a pertactin epitope that was likely shared
between the two.
Avidity Amplifies with Differential Gain
While these measurements looked at individual Mtd
trimers, the situation is vastly different during infection.
The phage has six tail fibers, and cryoelectron microscopy
data suggest that each fiber has two Mtd trimers at its base
[4,6] (A.H. and Z.H. Zhou, unpublished data). The existence of
12 Mtd trimers per phage raised the possibility that infection
was governed by multivalent interactions between the phage
and the surface-localized pertactin. To quantify how affinity
between Mtd and pertactin translated into multivalent avidity
[21], we turned again to SPR.
In contrast to the micromolar Kd’s of Mtd-P1 and Mtd-P6
for pertactin, phage expressing these Mtd variants had
dramatically amplified binding strengths, as characterized
by Kd’s of 6.89 6 1.77 and 6.23 6 4.29 pM for BPP-1 and BPP-
6, respectively (Figure 6 and Table 1). This ;106-fold
amplification partitioned as a ;104-fold increase in on-rate
and a ;102-fold decrease in off-rate. The more prominent
Figure 5. Dependency of Mtd Interactions on Major and Minor Pertactin Loops
(A) Coprecipitation of 60 lM (trimer concentration) Mtd-P1 (top), Mtd-M1 (middle), and Mtd-P6 with His-tagged wild-type Prn-E, Prn-ED399–407, Prn-
ED190–199, or no Prn-E using Ni2þ-NTA beads and visualized by SDS-PAGE and Coomassie staining. I, relative amount incubated with Ni2þ-NTA beads; E,
relative amount eluted from beads.
(B) Quantification of binding of Mtd-P1 (blue), Mtd-M1 (green), and Mtd-P6 (red) to Prn-ED399–407 and Prn-ED190–199, normalized by binding to Prn-E.
Values were corrected for background binding (no Prn-E) to Ni2þ-NTA beads.
doi:10.1371/journal.pbio.0060131.g005
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gains in on-rate suggested a complex and multistep associ-
ation mechanism for both Mtd-P1 and Mtd-P6. This was
consistent with the requirement for occupancy of two
binding sites in the case of Mtd-P1 (Figure 2) and the slow
on-rates of ;104 M1 s1 for both Mtd-P1 and Mtd-P6 (Table
1). The avidity of reovirus for mammalian cells shows a
similar prominence of on-rates in enhancing binding [22].
The binding of BPP-1 and BPP-6 phage to pertactin was
specific, as seen by the lack of binding by BIP-1 phage to
immobilized pertactin (Figure 6). BIP-1 expresses an Mtd
variant (Mtd-I1) that has no detectable affinity for pertactin
[7].
Most strikingly, we observed no interaction of BMP-1
phage with pertactin, despite the fact that the Mtd-M1 had
demonstrable affinity for pertactin (Figure 6 and Figure S5).
However, at a ;104-fold higher concentration of BMP-1 than
that used for BPP-1 or BPP-6, binding was observed (Figure
6). Binding by highly concentrated BMP-1 had a much slower
on-rate than that observed for either of the other two phages
but an off-rate that was apparently similar. A reliable fit to
the data could not be achieved for BMP-1, but the greater
concentration required to detect binding suggested an
apparent multivalent Kd,app of ;0.5 lM for BMP-1 (Materials
and Methods section). These results indicated that avidity
amplified binding strengths differentially. Binding strengths
for Mtd-P1 and Mtd-P6 were amplified ;106-fold, but the
binding strength for Mtd-M1 was amplified only ;103-fold.
Phage Binding to Bordetella
We lastly asked how the SPR measurements correlated with
in vivo association between the phage and Bordetella. First, we
quantified the amount of pertactin on the Bordetella surface to
be ;3000 molecules (Figure S6). On the basis of this, the
average pertactin density on the SPR chip was estimated to be
similar to that on the Bordetella surface (Materials and
Methods section). This suggested that results from SPR
measurements were applicable to understanding in vivo
association. To further confirm SPR results, we directly
examined binding between the phage and Bordetella. In
contrast to the kinetic measurements of the SPR experiment,
Figure 6. Affinity of Mtd and Avidity of Phage
The SPR sensorgrams showing association of Mtd-P1 (blue), Mtd-P6 (cyan), and Mtd-M1 (purple) and of phage BPP-1 (red), BPP-6 (pink), BIP-1 (thin
green), BMP-1 (yellow), and BMP-1 10,0003 (thick green) with biotinylated Prn-E immobilized on a streptavidin chip. Curves were chosen for display and
represent one of six (or five in the case of BMP-1 10,0003) different concentrations.
doi:10.1371/journal.pbio.0060131.g006
Table 1. Mtd–Pertactin Interactions (SPR)
Interaction kon (1/M s) koff (1/s) Kd (M) v
2
Mtd-P1 9.96 6 3.32 3 103 3.41 6 1.02 3 102 3.47 6 0.13 3 106 0.69 6 0.62
BPP-1 9.54 6 2.49 3 107 6.36 6 0.033 104 6.89 6 1.77 3 1012 0.18 6 .001
Mtd-P6 2.52 6 1.22 3 104 1.12 6 0.14 3 101 5.19 6 3.07 3 106 0.51 6 0.23
BPP-6 2.62 6 0.98 3 108 1.43 6 0.50 3 103 6.23 6 4.29 3 1012 0.20 6 0.04
Mtd-M1 ND ND
BMP-1 ND ND
10,0003 BMP-1 No fit No fit
BIP-1 ND ND
SD from duplicate measurements.
ND, not detected.
doi:10.1371/journal.pbio.0060131.t001
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precise quantification was difficult to achieve in these
equilibrium binding experiments due to limits on phage
concentrations. Nevertheless these experiments provided
estimates of binding strengths that confirmed the SPR results.
BPP-1 and BPP-6 bound BvgþBordetella tightly, with estimated
Kd’s in the picomolar or sub-picomolar range (Figure 7A and
7B). These values represent the specific component of
binding, as binding to Bvg– Bordetella was subtracted as
nonspecific background. In contrast, specific binding of BMP-
1 to Bvgþ Bordetella was too weak to be detected (Figure 7C),
agreeing with the near micromolar dissociation constant
suggested by SPR. This lack of binding was not due to a
deficiency in the phage, as BMP-1 bound tightly and
specifically to Bvg– Bordetella (Figure S7).
Figure 7. Phage Binding to Bordetella
Binding of (A) BPP-1, (B) BPP-6, and (C) BMP-1 to Bvgþ Bordetella. For BPP-1 and BPP-6, binding to Bvg– Bordetella was subtracted as nonspecific
background, and for BMP-1, binding to E. coli was subtracted as nonspecific background. Phage concentrations were determined by plaquing on
appropriate hosts and thus represent viable phage.
doi:10.1371/journal.pbio.0060131.g007
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Discussion
Mtd differed strikingly from antibodies and TCRs in its
mode of ligand recognition. Binding sites in antibodies and
TCRs are flexible and capable of adapting to ligands through
induced fit [23]. Binding sites in Mtd were instead static and
associated with pertactin in a lock-and-key fashion. Despite
their static nature, the binding sites in Mtd were also
remarkably adaptable to different epitopes. This was seen
in the sequence-unrelated major (‘‘TELPPIPGA’’) and minor
loops (‘‘LQPLQP’’) of pertactin being bound by chemically
and conformationally equivalent sites in Mtd-P1. Binding site
adaptability is consistent with Mtd having the capacity to
recognize diverse receptors and was essential for Mtd-P1
function because its association with pertactin was dependent
on both major and minor loops.
The structure of Mtd-P1Prn-E, however, did suggest some
limitations. Epitopes for Mtd are likely to be restricted to
portions of receptors that are flexible and therefore capable
of filling the static Mtd sites. A second limitation was
suggested by the pseudosymmetric mode of Mtd-P1Prn-E
association. This mode requires either a receptor large
enough (.30 A˚) to span multiple Mtd sites simultaneously
or displayed at high enough density on the bacterial surface
to do the same. Further work is needed to determine whether
the pseudosymmetric mode is general to other Mtd variants
and other receptors, but Mtd-P6 also appeared to bind
pertactin with a 3:1 stoichiometry (unpublished data). This is
consistent with pseudosymmetric association between Mtd-P6
and pertactin, but conclusive evidence awaits structure
determination of this complex.
Despite large differences in physical details between Mtd
and immunoreceptors, general principles for achieving
selective ligand recognition by variable repertoires emerged.
Mtd was reminiscent of antibodies and TCRs in its relatively
weak affinity (micromolar Kd) for its ligands. This weak
affinity was consistent with the suboptimal shape comple-
mentarity between Mtd and pertactin, reflecting the antici-
patory encounter between these two molecules. Such
anticipatory encounters contrast with coevolutionary pro-
cesses that give rise to high surface complementarity and
affinity [20]. Suboptimal interfaces likewise occur between
(primary) antibodies and antigens and are reflected in the
relatively weak affinities of antibody–antigen complexes, as
characterized by micromolar Kd’s [24–27]. Even lower affinity
interactions, in the tens of micromolar Kd range, are
observed for TCRs binding to major histocompatibility
complex-peptide complexes [28]. The prevalence of micro-
molar Kd’s suggests that high-affinity binding variants (i.e,
ones that have high complementarity to their ligands) occur
only rarely in variable repertoires (Figure 8).
Micromolar Kd’s stand in contrast to the binding strengths
required for biological effect, for example, the;20–50 nM Kd
required for a protective antibody response [29] or picomolar
Kd shown here to support Bordetella phage infectivity. The
problem of attaining high affinity is solved by multivalent
avidity [21]. For Bordetella phage, avidity amplified the
strength of productive binding events ;106-fold, translating
a micromolar Kd for the monovalent Mtd–pertactin inter-
action to a picomolar Kd for the multivalent phage–
bacterium interaction. In the immune system, avidity has
been documented to amplify monovalent interactions for
immunoglobulin G’s between ;20- and 103-fold and for
immunoglobulin M’s up to ;106-fold [24,30]. Avidity also has
been observed in interactions of immunoglobulin-G-bound
antigens with B cell receptors [25] and has been noted to
amplify intercellular interactions between TCRs and major
histocompatibility complex-peptide complexes [28,31,32].
Monomeric major histocompatibility complex-peptide com-
plexes are unstimulatory towards T cells, in contrast to
trimeric and tetrameric complexes, which constitute potent
stimuli [33]. Amplification of the strength of individual
binding events by avidity enables variants with suboptimal
complementarity for their ligands to nevertheless achieve
binding strengths required for biological effect. This results
in an expansion in the number of productive interactions
available to a variable repertoire (Figure 8).
For every binding event that is amplified by avidity and
made productive, like that of Mtd-P1 or Mtd-P6 with
pertactin, there are many more that are just slightly weaker,
like that of Mtd-M1 with pertactin, and still more that are
even weaker, and so on (Figure 8). Yet, what emerges from
this pool of binding events with graded affinities is a highly
selective response, with Mtd-P1 and Mtd-P6 supporting
infectivity through pertactin but not Mtd-M1. The explan-
ation for this lies in the differential gain of avidity.
Avidity amplifies the strength of individual binding events
by the exponential factor aN (Figure 8) [21]. The magnitude
of aN depends on the details of receptor density and
geometry, with a being the degree of cooperativity and N
the valency of interaction. Significantly, aN was ;2 for Mtd-
P1 and Mtd-P6 as well as for Mtd-M1, meaning that neither
the degree of cooperativity nor the valency differed between
productive and nonproductive interactions. This is consistent
with Mtd-P6 and Mtd-M1 having a common pertactin
epitope. Selectivity in infection instead emerged from aN,
Figure 8. Avidity Provides Amplification and Differential Gain
(Top) Distribution of variable proteins and their individual binding
strengths (monovalent affinities) to a particular ligand (triangle), with
two variants depicted (red and blue). (Bottom) Avidity amplifies
monovalent affinities through the exponential factor aN, resulting in
some members of the repertoire crossing a threshold required for
productive interaction and biological effect. Differences between
monovalent affinities are also amplified such that slightly differing
monovalent affinities become vastly differing multivalent avidities.
doi:10.1371/journal.pbio.0060131.g008
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which effectively squared the ;106 M Kd’s of Mtd-P1 and
Mtd-P6 for pertactin into the picomolar range for the phage
but the ;0.5 3 103 M Kd of Mtd-M1 only to the near
micromolar range. Phage concentrations are limited to
;1012 M, explaining why a Kd in the near micromolar range
for BMP-1 rendered the interaction with Bvgþ Bordetella
nonproductive. Thus, avidity not only amplified the strength
of individual binding events but importantly also amplified
the differences between such events. A ;100-fold difference
in the micromolar Kd range for Mtd (i.e., 3–5 lM for Mtd-P1
and Mtd-P6 versus ;500 lM for Mtd-M1) resulted in a ;105-
fold difference in the picomolar Kd range for the phage (i.e.,
;6–7 pM for BPP-1 and BPP-6 versus ;0.5 lM for BMP-1).
Steps subsequent to binding may further enhance the
selectivity initially provided by the differential gain of avidity
[34].
The essential role of avidity in the responsiveness and
selectivity of the Mtd repertoire predicts multivalency to be a
general feature of variable repertories, consistent with the
prevalence of multivalency in the adaptive immune system. It
is striking that both Mtd and the immune system have arrived
at common solutions for achieving productive interactions.
In each case, only moderate surface complementarities (SC ’
0.65) are required for productive interactions, as the micro-
molar Kd’s of these binding events are amplified by avidity to
high affinity ranges. This amplification relaxes the demand
for optimal complementarity and as a consequence expands
the scope of ligands capable of being recognized, thereby
making the repertoire more responsive.
The amplification effect of avidity is powerful, and it is
conceivable that interactions with even worse complemen-
tarities and affinities (e.g., millimolar Kd) could be made
productive by avidity. For this, the exponential factor aN
would need to be large enough to compensate for these very
low affinities. However, such potent amplification would also
come at a cost, creating a repertoire that is overly responsive
and therefore lacking selectivity and most likely effectiveness
as well (due to tendencies toward self-aggregation). It appears
that this is the reason that variable repertoires have evolved
to have moderate values of aN. Interactions by immunoglo-
bulin G’s have been documented to be amplified by aN values
of ;1.2, and even immunoglobulin M’s, which are potentially
pentavalent, have been documented to be amplified by
moderate aN values of ;2.5 [30]. This is similar to our
results, showing that potentially dodecavalent Mtd displayed
by Bordetella phage is amplified by aN of only ;2.
These observations suggest the existence of an optimal
balance between surface complementarity and avidity in
variable repertoires. Moderate values in each (SC ’ 0.65 and
aN ’ 2) are seen to support responsiveness and selectivity in
recognition by the Bordetella bacteriophage DGR and the
immune system. In comparison, an imbalance towards low aN
and consequent demand for high SC would lead to sparse
recognition (i.e., nonresponsiveness), and an imbalance
towards high aN and resulting tolerance of low SC would
lead to promiscuous binding (i.e., nonselectivity). Despite
depending on dramatically different modes of ligand recog-
nition, the Bordetella bacteriophage DGR and the immune
system have evolved quantitatively similar principles for
selective ligand recognition. These similarities suggest that a
narrow set of conditions endow variable repertoires with
responsiveness and selectivity.
Materials and Methods
Phage evolution. BMP-1(Dbrt) lysogens were induced, as previously
described [4], from B. bronchiseptica RB50 expressing Brt ectopically
from the B. bronchiseptica filamentous hemagglutinin promoter on the
pBBR1MCS-derived, medium-copy plasmid pMin1 (M. Xu and J.F.
Miller, unpublished data). Resulting phage were propagated on B.
bronchiseptica RB54 (Bvg–) and then selected for plaque formation on
B. bronchiseptica RB53 (Bvgþ) [35]. These BPP phage were screened for
dependency on pertactin for infection, as assayed by their inability to
form plaques on B. bronchiseptica RB50(Dprn) (Bvgþ). Pertactin-
dependent phage were then lysogenized, and the variable regions of
single-colony lysogens were sequenced before reinduction of phage.
Mtd variants were cloned, expressed, and purified as described
previously, as was His-tagged Prn-E (residues 38–640) [7]. Loop
deletions of Prn-E (D190–199 and D399–407) containing an N-
terminal His tag (MGSSHHHHHHSSGLVPRGSHMAS) were con-
structed by strand-overlap extension PCR [36] and expressed using
pET28b (Novagen). These mutant proteins were refolded from
inclusion bodies and purified as previously described [7]. Size-
exclusion chromatography (Superdex 200) was used to confirm the
nonaggregated and monomeric state of these mutant proteins. In
vivo biotinylation of Prn-E was carried out through expression of
pertactin residues 38–640 carrying an N-terminal biotinylation
sequence (MSGLNDIFEAQKIEWHEGAPELE) from pAN-5 (AviTag)
in Escherichia coli AVB101. Biotinylated Prn-E was expressed as
inclusion bodies and refolded and purified as above.
Crystallization and structure determination. Mtd-P1Prn-E com-
plexes were formed by mixing ;1.6-fold molar excess of purified
Mtd-P1 trimers with His-tagged Prn-E and separating complexes
from unbound proteins using successive Ni2þ-chelation and size-
exclusion (Superdex 200) chromatographies. Protein crystals were
grown by the sitting drop, vapor diffusion method at 25 8C by mixing
equal volumes of 10 mg/ml Mtd-P1Prn-E (e280calc 254,050 M1 cm1)
and precipitant (2 M NaCl, 100 mM Tris, pH 8.5, 200 mM Li2SO4).
X-ray diffraction data were collected at 100 K using synchrotron
radiation at the Advanced Light Source (k¼1.000 A˚; oscillation range
0.358; beamline 5.0.1) from crystals that had been cryoprotected by
soaking in precipitant solution containing 25% glycerol. Crystals of
Mtd-P1Prn-E belong to space group P61 and contain two Mtd-
P1Prn-E complexes in the asymmetric unit. Diffraction data were
processed and scaled using HKL2000 [37], and the structure was
determined by the molecular replacement technique using Amore
[38] and Mtd-P1 as the search model. The model was built and refined
using O [39] and Refmac 5.2 [38], respectively. Noncrystallographic
symmetry restraints were used in initial stages of refinement but
removed in later stages, whereupon translation–libration–screw
(TLS) refinement was used with each polypeptide chain set to an
independent TLS group and all atomic B-factors set to the Wilson B-
factor value of 81.5 A˚2. This was followed by restrained positional and
B-factor refinement (without prior phase information restraints).
Electron density for loops 265–291 (the RGD loop) and 349–354 of
Prn-E were not visible, and these residues were not modeled. Except
for these loops, no breaks in the main chain were evident for Mtd-P1
or Prn-E. No residues are in the disallowed region of the
Ramachandran plot, with 81.7% (of the 2,170 residues other than
glycine or proline) being in the most favored region and 17% in the
additional allowed region. Molecular graphics were made using
PyMol (http://pymol.sourceforge.net/).
Coprecipitation assay. For assays with Prn-E loop deletion mutants,
50 lL of His-tagged Prn-E, Prn-E(D190–199), and Prn-E(D399–407) (8
lM) were incubated (5 min, 25 8C) with 30 ll of Ni2þ-nitrilotriacetic
(NTA) agarose beads (Sigma). For preparation of beads, 50 lL of Ni2þ-
NTA agarose bead slurry (50% suspension in 30% ethanol) was
centrifuged, and 20 lL of the overlying solution was removed. The
Prn-E constructs were then added to the beads, and unbound Prn-E
was removed by centrifugation and removal of overlying solution. Mtd
(60 lM trimer) was added to the protein–bead mixture, incubated for
5 min at 25 8C, and washed with binding buffer (150 mM NaCl and 50
mM Tris, pH 8.0) three times. Bound protein was eluted with binding
buffer supplemented with 500 mM imidazole, then visualized by SDS-
PAGE. The final wash was devoid of protein. For quantification of
binding in the coprecipitation assay, the intensity of Mtd bound to
His-tagged Prn-E, Prn-E(D190–199), or Prn-E(D399–407) was meas-
ured using Kodak 1D imaging software (version 3.5.0), and the
intensity of Mtd bound in the absence of His-tagged Prn-E was taken
as background and subtracted from this value.
Comparison of Mtd-P6 and Mtd-M1 affinity for Prn-E was carried
out as above, except that varying concentrations of Mtd were
incubated with 80 lM Prn-E (5 min, 25 8C) prior to addition of
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Ni2þ-NTA agarose beads. Beads (30 ll) were then added, and samples
were handled as above. Intensities of protein bands were quantified
from Coomassie stained SDS-PAGE gels using Kodak 1D imaging
software. A standard concentration curve of known Mtd quantities
was used to ensure linearity of measurements. The apparent Kd of
Mtd-M1 for Prn-E was estimated by identifying total concentrations
of Mtd-P6 and Mtd-M1 that yield equivalent amounts of bound Mtd.
The Kd for Mtd-P6, as determined by SPR, was then used in the
Langmuir isotherm to calculate the concentrations of bound and
free Mtd-P6. The concentration of bound Mtd-P6 was applied to
Mtd-M1 in the Langmuir isotherm to determine its apparent Kd.
Two equivalent concentrations of Mtd-P6 and Mtd-M1 (3 and 25 lM
Mtd-P6 and Mtd-M1, respectively, and 8 and 63 lM Mtd-P6 and
Mtd-M1) were used to estimate an apparent Kd of ;0.5 mM for Mtd-
M1.
Surface plasmon resonance The SPR measurements were per-
formed using a Biacore 3000 at 25 8C. Approximately 100 response
units (RUs) of biotinylated Prn-E were immobilized on the surface of
a streptavidin sensor chip in running buffer (150 mM NaCl, 50 mM
Tris, pH 8.0, and 0.005% Tween 20); a streptavidin sensor chip
without any immobilized protein was used as a blank. Mtd-P1, Mtd-
M1, and Mtd-P6 proteins and BPP-1, BMP-1, BIP-1, and BPP-6 phage
were injected in running buffer at 30 ll/min for 2 min with the data
collection rate set to high. A 2 min wash delay was used for complete
dissociation of Mtd from Prn-E and accurate fitting of dissociation
data. The data were analyzed using BIA evaluation 3.0 software for
nonlinear curve fitting using a single-site model. Global fitting was
used to analyze association and dissociation curves, except for BMP-1,
which could not be fit. Six concentrations were used for each global
fit, and experiments were carried out in duplicate. Concentrations of
Mtd-P1 ranged from ;20 to ;1253 109 M; of Mtd-P6 from ;2503
109 to ;1.53 106 M; of BPP-1 phage from ;1.2 to ;3.73 1015 M;
of BPP-6 phage from ;1 to ;23 1016 M; and of BMP-1 phage from
;3.5 to ;8.503 1012 M. No interactions were detected for Mtd-M1
in the concentration range from 21 3 109 to 2.1 3 106 M and for
BIP-1 phage in the concentration range from 8.3 3 1016 to 8.3 3
1015 M. Concentrations of BMP-1 equivalent to those used for BPP-1
and BPP-6 (e.g., 3.683 1015 M) did not yield detectable binding.
For SPR assays using phage, BPP-1(Dbrt), BPP-6(Dbrt), and BMP-
1(Dbrt) were harvested from B. bronchiseptica RB50. Cultures contain-
ing induced phage were treated with chloroform and centrifuged
twice (8,000g, 10 min) to remove cell debris. Phage were then
concentrated by centrifugation (13,000g, 3 h) in Corex tubes, and
pellets (which contain phage) were resuspended in 50 mM Tris, pH
7.5, 0.1 M NaCl, 8 mM MgSO4, and 0.01% gelatin. Phage then were
concentrated further by ultrafiltration (Amicon, YM-30) into running
buffer. The number of plaque forming units per unit volume was
determined from this final phage stock (on the appropriate B.
bronchiseptica background), and this value was converted to molarity
using Avogadro’s number.
BIA simulation was used to estimate a Kd limit for Mtd-M1. The
estimation is based on the observations that Mtd-P6 produces a
binding event with an RMAX value of 66.6 RU and the baseline noise
level of detection is 1 RU. If it is assumed that either the on-rate or
the off-rate of Mtd-M1 is the same as that for Mtd-P6, then the fact
that 2 lM Mtd-M1 yields no detectable binding signal is consistent
with an apparent Kd of 450 lM.
BIA simulation also was used to estimate an apparent Kd limit for
BMP-1. The off-rate of BMP-1 was set to that of BPP-6 (1.43 3 103
s1), and the RMAX value of BMP-1 was set to that of BPP-6 (2.96310
6
RU). The fact that a concentration of BMP-1 of 8.50 3 1012 M
produces a binding event of 10 RU is consistent with an apparent Kd
of ;0.5 lM.
Phage binding to Bordetella. BPP-1(Dbrt), BPP-6(Dbrt), and BMP-
1(Dbrt) phage were prepared with slight modifications to the above
protocol. BPP-1(Dbrt) and BPP-6(Dbrt) were harvested from bacterial
cultures grown in Luria broth containing 40 mM MgSO4, and BPP-
6(Dbrt) was concentrated by ultracentrifugation at 4 8C (100,000g, 3 h).
Phage concentrations were determined by plaquing on the appropriate
host, B. bronchiseptica RB53 (Bvgþ) for BPP-1 and BPP-6 and B.
bronchiseptica RB54 (Bvg–) for BMP-1. BPP-1 and BPP-6 at ;109 plaque
forming units ml1 were incubated with an excess of B. bronchiseptica
RB53 and RB54 (33 109 bacteria ml1) for 5 min, and unbound phage
were isolated by filtering through a 0.8 lm cutoff membrane.
Concentrations of BMP-1 up to 1 3 109 ml1 were incubated with
RB53, RB54, and E. coli TOP10, as above. Free (unbound) phage were
quantified by plaquing onRB53 orRB54 B. bronchiseptica, as appropriate.
The binding isotherms were fit by nonlinear regression to yield a Kd.
Quantification of bacterially associated pertactin. The quantity of
bacterially-associated Prn-E was determined by immunoblotting,
using known concentrations of purified Prn-E as a standard. Over-
night cultures of B. bronchiseptica RB53 (Bvgþ) and RB54 (Bvg–) were
pelleted by centrifugation and washed twice with wash buffer (150 mM
NaCl and 50 mM Tris, pH 8.0), then resuspended in wash buffer to a
final A600 of 1.0 (equivalent to 3.3310
9 bacteria ml1). Approximately
10 ll of each culture were lysed by boiling in SDS-PAGE sample buffer,
separated on by 10% SDS-PAGE, and visualized by western blot using
PeM19 as the primary antibody and an anti-mouse horseradish
peroxidase conjugate as the secondary antibody. PeM19 is a mouse
monoclonal antibody that recognizes the linear epitope RELSA on
Prn-E [40]. Fluorescence from blots was quantified with a Typhoon
8600 (Amersham Pharmacia) imaging scanner and confirmed to be
within the linear range of detection. Thesemeasurements yield a value
of 3,000 molecules of pertactin per bacterium.
The approximate surface area of a Gram-negative bacterium is
6 3 106 mm2, resulting in a surface density for pertactin of 8.26 3
1016 mol mm2. The surface density of Prn-E on the SPR chip is 1.67
3 1015 mol mm2, as determined by the 100 RU of Prn-E bound to
the chip.
Supporting Information
Figure S1. Receptor-Binding Sites of Mtd
The three independent receptor-binding sites of trimeric Mtd are
denoted by dotted lines. The view is looking at the base of the
pyramid-shaped Mtd trimer. Individual Mtd protomers of unbound
Mtd-P1 are depicted in ribbon representation in blue, red, and gold.
The b2b3 loop of one protomer contributes invariant residues
Tyr322 and Tyr333 to the binding site of a neighboring protomer.
Side chains of variable residues are shown, and the trimer axis is
indicated by the black triangle in the middle.
Found at doi:10.1371/journal.pbio.0060131.sg001 (1.9 MB PDF).
Figure S2. Conformations of Major and Minor Pertactin Loops
(A and B) The conformations of the (A) major and (B) minor loops
from B. bronchiseptica pertactin bound to Mtd are in yellow stick
representation, and the conformations of these same loops from free
B. pertussis pertactin [12] are in purple stick representation. Sequence
alignment between B. bronchiseptica (B.b.) and B. pertussis (B.p.)
pertactin in this region is shown below. The superposition is based
on 492 Ca atoms of bound B. bronchiseptica pertactin and unbound B.
pertussis pertactin (root-mean-square deviation 0.83 A˚).
Found at doi:10.1371/journal.pbio.0060131.sg002 (1.2 MB PDF).
Figure S3. Molecular Surface Representations of Receptor-Binding
Sites of Mtd Variants
(A) The molecular surface of Mtd-M1, as experimentally determined
[7], is shown (green, hydrophobic residues; red, hydrophilic residues),
with underlying backbone in gray and side chain carbons, oxygens,
and nitrogens in gray, red, and blue, respectively. Mtd residues are
labeled in blue.
(B) Themolecular surface of Mtd-P6, as modeled based onMtd-M1. The
five Mtd-P6 residues differing from Mtd-M1 were modeled in rotamer
conformations that avoided steric clashes with neighboring atoms.
Found at doi:10.1371/journal.pbio.0060131.sg003 (978 KB PDF).
Figure S4. Fitting Residuals for Surface Plasmon Resonance Sensor-
grams
(A) Residuals for fitting of Mtd-P1. Residuals for fits to the association
phase occur between 0 and 120 s, and residuals for fits to the
dissociation phase occur between 120 and 250 s. Gaps between
residuals represent data that was not included in fitting.
(B) Residuals for fitting of Mtd-P6.
(C) Residuals for fitting of BPP-1.
(D) Residuals for fitting of BPP-6.
Found at doi:10.1371/journal.pbio.0060131.sg004 (1.0 MB PDF).
Figure S5. Association of Mtd-P6 and Mtd-M1 with Pertactin
Coprecipitation of varying concentrations of Mtd-P6 and Mtd-M1
(total trimer concentrations indicated above lanes) with 80 lM Prn-E
using Ni2þ-NTA beads and visualized by SDS-PAGE and Coomassie
staining. Concentrations of MtdPrn-E complexes are equivalent
when 3 lM Mtd-P6 is incubated with Prn-E as when 25 lM Mtd-M1 is
incubated with Prn-E, and when 8 lMMtd-P6 is incubated with Prn-E
as when 63 lM Mtd-M1 is incubated with Prn-E.
Found at doi:10.1371/journal.pbio.0060131.sg005 (531 KB PDF).
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Figure S6. Quantification of Bordetella-Associated Pertactin
Western blot probed with the anti-pertactin monoclonal antibody
PeM19 of known quantities of purified Prn-E (50, 25, 12, 6, and 1 ng),
10 lL of an A600¼1 culture of B. bronchiseptica RB54, and 10, 5, and 2.5
lL of an A600¼ 1 culture of B. bronchiseptica RB54. Graph below shows
linearity of secondary antibody fluorescence in detection of Prn-E
standards (with 50 ng omitted due to nonlinearity).
Found at doi:10.1371/journal.pbio.0060131.sg006 (265 KB PDF).
Figure S7. Phage Binding to Bordetella
Binding of BMP-1 to Bvg– Bordetella. While the identity and number of
receptors is unknown, the data can be fit with a single-site binding
model that yields a Kd of 2.7 3 10
13 M. Binding to E. coli was
subtracted as nonspecific background.
Found at doi:10.1371/journal.pbio.0060131.sg007 (116 KB PDF).
Table S1. Data Collection and Refinement Statistics (Molecular
Replacement)
Found at doi:10.1371/journal.pbio.0060131.st001 (76 KB PDF).
Table S2. Mtd-P1 Residues Buried by Contact with Prn-E
Found at doi:10.1371/journal.pbio.0060131.st002 (45 KB PDF).
Table S3. Prn-E Residues Buried by Contact with Mtd-P1
Found at doi:10.1371/journal.pbio.0060131.st003 (48 KB PDF).
Accession Numbers
Accession numbers for genes mentioned in this paper from the
National Center for Biotechnology Information (http://www.ncbi.nlm.
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The structure coordinates of Mtd-P1 (PDB ID 1YU0) from the
Protein Data Bank (PDB) (http://www.rcsb.org/pdb) were used for model
building via molecular replacement. The structure coordinates of Mtd-
P1Prn-E determined in this study are deposited as PDB ID 2IOU.
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